Tannin Capital »

Vertex Pharmaceuticals Incorporated shares owned by Tannin Capital

Quarter-by-quarter ownership of Vertex Pharmaceuticals Incorporated (VRTX) shares owned by Tannin Capital from 13F filings

Historical chart of Tannin Capital investment in Vertex Pharmaceuticals Incorporated

Tip: Access up to 7 years of quarterly data

All positions including Vertex Pharmaceuticals Incorporated held by Tannin Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Vertex Pharmaceuticals Incorporated by Tannin Capital

Quarter filed Position value Share count Share price at filing
2026-03-31 $272k 609 446.54

More positions owned by Tannin Capital

Global X Fds 1-3 Month T-bill (CLIP)
Berkshire Hathaway Inc Del Cl A (BRK.A)
JPMorgan Chase & Co. (JPM)
Apple (AAPL)
Alphabet Cap Stk Cl A (GOOGL)
NVIDIA Corporation (NVDA)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Goldman Sachs (GS)
Abbvie (ABBV)
Broadcom (AVGO)
Vanguard Index Fds Growth Etf (VUG)
Microsoft Corporation (MSFT)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Home Depot (HD)
Johnson & Johnson (JNJ)

View all positions for Tannin Capital

Top funds holding Vertex Pharmaceuticals Incorporated

Capital World Investors
Vanguard Group
BlackRock
Capital Research Global Investors
Vanguard Capital Management
State Street Corporation
Geode Capital Management
Vanguard Portfolio Management
Capital Research and Management Company - Division 3
Alliancebernstein
Loomis, Sayles and
Wellington Management Company
Victory Capital Management
Ubs Global Asset Management Americas
Jennison Associates

View all funds holding Vertex Pharmaceuticals Incorporated